Entering text into the input field will update the search result below

Champions Oncology reports FQ2 results

  • Champions Oncology (NASDAQ:CSBR -6%) FQ2 results: Revenues: $3M (+57.9%); R&D Expense: $0.9M (-25.0%); SG&A: $2.5M (-3.8%); Net Loss: (2.5M) (+19.4%); Loss Per Share: ($0.29) (+47.3%); Non-GAAP Loss Per Share: ($0.24) (+52.0%); Quick Assets: $4.2M (-55.3%).
  • No guidance given.

Recommended For You

More Trending News

About CSBR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CSBR--
Champions Oncology, Inc.